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It is well established in international literature that patients with end stage liver disease 
(ESLD) commonly develop a subtle form of neuropsychological dysfunction, known as 
minimal hepatic encephalopathy (MHE). MHE is characterised by subtle deficits in attention, 
visuospatial construction, psychomotor speed and executive function which are detected 
through neuropsychological testing. Patients with MHE are inclined to develop overt hepatic 
encephalopathy (HE) as ESLD severity increases. Furthermore, patients who undergo a 
successful liver transplant (LT) have been found to show significant improvements in 
cognitive functioning. However, the findings of previous studies have been inconsistent. As 
MHE is not being detected in South Africa, barring for the Wits University Donald Gordon 
Medical Centre (WDGMC), it is impossible to transpose the findings of the previous studies 
to the South African context. In the present study, 13 patients on the waiting list for a LT as 
well as 18 patients who had previously undergone an LT at the WDGMC were examined for 
their level of cognitive functioning on 3 neuropsychological assessments, namely the 
Repeatable Battery of Neuropsychological Status, the Cognitive Trail Making Test and the 
Stroop Effect Test. The same patients additionally were investigated for their level of 
psychological distress. The current study found that patients who are currently awaiting a LT 
have a progressed deficit in the index of attention from their initial test to a six month follow 
up. Patients who had undergone a LT, appeared to have improved areas in attention yet a 
deficit remained in visuospatial construction. Similarly, patients who had undergone a LT 









“The fact that the mind rules the body is, in spite of its neglect by 
biology and medicine, the most fundamental fact which we know 
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